France Bed Holdings Co Ltd

France Bed Holdings Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.42, below the industry median of 0.65, indicating a lower reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.48, suggesting strong short-term liquidity. However, the firm's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 7.26%, which is below the industry median of 9.5%, and a return on assets (ROA) of 4.16%, also below the median of 5.8%. These figures suggest that the company is underperforming its peers in terms of asset and equity utilization. The gross profit margin of 54.5% is in line with the industry median, but the operating margin of 7.7% is below the median of 9.2%, indicating inefficiencies in operating cost control. The company's revenue is split between two segments: Medical Service and Interior Healthy. The Medical Service segment is the primary revenue driver, with a focus on nursing beds and welfare equipment. The Interior Healthy segment contributes to the company's product diversification but is less prominent in terms of revenue share. Geographically, the company is heavily concentrated in Japan, with no significant international revenue disclosed. Looking ahead, the company is projected to experience a 2.3% revenue growth in the current fiscal year and a 1.8% growth in the next fiscal year. These growth rates are below the industry median of 4.5% and 5.1%, respectively, indicating a slower growth trajectory compared to its peers. The company's capital expenditure of -4.95 billion JPY suggests a reduction in investment, which may impact long-term growth potential. The risk assessment highlights a medium liquidity risk due to the negative net cash position after debt. The dilution risk is rated as low, with no significant dilution potential identified in the basic shares outstanding. The company has not made any recent equity issuances or announced plans for additional share offerings, which supports the low dilution risk rating. No recent filings or transcripts have been disclosed that would indicate significant operational or strategic changes.